Key facts
- This page summarizes Trium Capital LLP's Form 3 filing for Mural Oncology plc (MURA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2025, 08:17.
Trium Capital LLP - 22 Aug 2025 Form 3 Insider Report for Mural Oncology plc (MURA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MURA
- Reported as of
- 22 Aug 2025
- Net transaction value
- $0
- Reporting owner signature
- Fredrik Ostlund
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Trium Capital LLP filed Form 3 for Mural Oncology plc (MURA) on 02 Sep 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001963860
Primary reporting owner
Trium Capital LLP
- Relationship
- 10%+ Owner
- Address
- 60 GRESHAM STREET, LONDON, UNITED KINGDOM
- Signature
- Fredrik Ostlund
- Signature date
- 02 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MURA US
holding
Mural Oncology Plc - MURA US EQUITY
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,760,097
- Date
- 22 Aug 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.